Granules’ four API facilities have successfully passed USFDA inspections in the past 12 months. All of the company’s facilities including its finished dosage and PFI facility are approved by leading regulatory agencies including the USFDA, EDQM, Health Canada and Korean FDA.
For Real Time News & Trading Trends Keep Liking Epic Research Private Limited
Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+
For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH
0 comments:
Post a Comment